Shen Y, Zhang P, He A, Wang J, et al. Azacitidine monotherapy versus combination regimens as post-HSCT maintenance therapy in high-risk myeloid malignancies: a retrospective cohort study. Int J Hematol 2026;123:270-278.
PMID: 41219677